Does Rallies show Form 4 insider transactions for INSP?

Yes. Rallies tracks INSP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is INSP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for INSP. It does not provide personalized investment advice.

INSP (Inspire Medical Systems, Inc.) Stock Analysis - Insider Trades

Inspire Medical Systems, Inc. (INSP) is a publicly traded Healthcare sector company. As of May 21, 2026, INSP trades at $44.14 with a market cap of $1.21B and a P/E ratio of 9.83. INSP moved +3.76% today. Year to date, INSP is -53.42%; over the trailing twelve months it is -70.58%. Its 52-week range spans $39.61 to $216.01. Analyst consensus is neutral with an average price target of $54.36. Rallies surfaces INSP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading INSP stock inside the company?

Recent INSP insider activity includes Rondoni John sold 109, mcCormick Shawn sold 1.20K, mcCormick Shawn sold 2.00K, Buchholz Richard sold 11.00K, and Curet Myriam sold 4. Rallies tracks insider transaction dates, shares, prices, and estimated values.

INSP Key Metrics

Key financial metrics for INSP
Metric	Value
Price	$44.14
Market Cap	$1.21B
P/E Ratio	9.83
EPS	$4.46
Dividend Yield	0.00%
52-Week High	$216.01
52-Week Low	$39.61
Volume	0
Avg Volume	0
Revenue (TTM)	$915.25M
Net Income	$131.14M
Gross Margin	85.78%

Recent INSP Insider Trades

Rondoni John sold 109 (~$10.90K) on Jan 9, 2026.
mcCormick Shawn sold 1.20K (~$166.80K) on Dec 2, 2025.
mcCormick Shawn sold 2.00K (~$254.96K) on Nov 28, 2025.
Buchholz Richard sold 11.00K (~$1.03M) on Aug 29, 2025.
Curet Myriam sold 4 (~$309.102) on Aug 8, 2025.

Latest INSP News

Inspire Medical Systems Downgraded Despite $204.5M Q1 Revenue and $0.10 EPS — May 5, 2026
Inspire Medical Systems Q1 Revenue Rises 1.6% to $204.6M, Guides $825–875M — May 4, 2026
Inspire Medical Systems Shares Drop 7.5% After 0.5% PPI Surge — Feb 27, 2026
Inspire Medical Systems Shares Surge 19.7% on New CMS C-Codes for Inspire V — Feb 26, 2026
Inspire Medical Systems Confronts Reimbursement Headwinds as Price Target Falls to $95 — Feb 15, 2026

INSP Analyst Consensus

13 analysts cover INSP: 0 strong buy, 3 buy, 10 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $54.36.

Common questions about INSP

Who is trading INSP stock inside the company?: Recent INSP insider activity includes Rondoni John sold 109, mcCormick Shawn sold 1.20K, mcCormick Shawn sold 2.00K, Buchholz Richard sold 11.00K, and Curet Myriam sold 4. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for INSP?: Yes. Rallies tracks INSP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is INSP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for INSP. It does not provide personalized investment advice.